Compounds > lactitol
Page last updated: 2024-09-04

lactitol and framycetin

lactitol has been researched along with framycetin in 7 studies

Compound Research Comparison

Studies
(lactitol)		Trials
(lactitol)		Recent Studies (post-2010)
(lactitol)		Studies
(framycetin)		Trials
(framycetin)		Recent Studies (post-2010) (framycetin)
19748418,151460653

Protein Interaction Comparison

ProteinTaxonomylactitol (IC50)framycetin (IC50)
30S ribosomal protein S6Escherichia coli K-120.032
30S ribosomal protein S7Escherichia coli K-120.032
50S ribosomal protein L15Escherichia coli K-120.032
50S ribosomal protein L10Escherichia coli K-120.032
50S ribosomal protein L11Escherichia coli K-120.032
50S ribosomal protein L7/L12Escherichia coli K-120.032
50S ribosomal protein L19Escherichia coli K-120.032
50S ribosomal protein L1Escherichia coli K-120.032
50S ribosomal protein L20Escherichia coli K-120.032
50S ribosomal protein L27Escherichia coli K-120.032
50S ribosomal protein L28Escherichia coli K-120.032
50S ribosomal protein L29Escherichia coli K-120.032
50S ribosomal protein L31Escherichia coli K-120.032
50S ribosomal protein L31 type BEscherichia coli K-120.032
50S ribosomal protein L32Escherichia coli K-120.032
50S ribosomal protein L33Escherichia coli K-120.032
50S ribosomal protein L34Escherichia coli K-120.032
50S ribosomal protein L35Escherichia coli K-120.032
50S ribosomal protein L36Escherichia coli K-120.032
30S ribosomal protein S10Escherichia coli K-120.032
30S ribosomal protein S11Escherichia coli K-120.032
30S ribosomal protein S12Escherichia coli K-120.032
30S ribosomal protein S13Escherichia coli K-120.032
30S ribosomal protein S16Escherichia coli K-120.032
30S ribosomal protein S18Escherichia coli K-120.032
30S ribosomal protein S19Escherichia coli K-120.032
30S ribosomal protein S20Escherichia coli K-120.032
30S ribosomal protein S2Escherichia coli K-120.032
30S ribosomal protein S3Escherichia coli K-120.032
30S ribosomal protein S4Escherichia coli K-120.032
30S ribosomal protein S5Escherichia coli K-120.032
30S ribosomal protein S8Escherichia coli K-120.032
30S ribosomal protein S9Escherichia coli K-120.032
50S ribosomal protein L13Escherichia coli K-120.032
50S ribosomal protein L14Escherichia coli K-120.032
50S ribosomal protein L16Escherichia coli K-120.032
50S ribosomal protein L23Escherichia coli K-120.032
30S ribosomal protein S15Escherichia coli K-120.032
50S ribosomal protein L17Escherichia coli K-120.032
50S ribosomal protein L21Escherichia coli K-120.032
50S ribosomal protein L30Escherichia coli K-120.032
50S ribosomal protein L6Escherichia coli K-120.032
30S ribosomal protein S14Escherichia coli K-120.032
30S ribosomal protein S17Escherichia coli K-120.032
30S ribosomal protein S1Escherichia coli K-120.032
50S ribosomal protein L18Escherichia coli K-120.032
50S ribosomal protein L2Escherichia coli K-120.032
50S ribosomal protein L3Escherichia coli K-120.032
50S ribosomal protein L24Escherichia coli K-120.032
50S ribosomal protein L4Escherichia coli K-120.032
50S ribosomal protein L22Escherichia coli K-120.032
50S ribosomal protein L5Escherichia coli K-120.032
30S ribosomal protein S21Escherichia coli K-120.032
50S ribosomal protein L25Escherichia coli K-120.032
50S ribosomal protein L36 2Escherichia coli K-120.032

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19902 (28.57)18.7374
1990's1 (14.29)18.2507
2000's2 (28.57)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Capocaccia, L; Riggio, O1
Candiani, C; Concia, E; Perversi, L; Scevola, D; Zambelli, A1
Clark, ML; Dawson, AM; Mahida, YR; Palmer, KR; Patil, DH; Rees, R; Silk, DB; Westaby, D1
Als-Nielsen, B; Gluud, C; Gluud, LL1
Als-Nielsen, BE; Gluud, CN; Gluud, LL1
Fehérvári, I; Gerlei, Z; Görög, D; Kóbori, L; Nemes, B1
Gluud, LL; Morgan, MY; Vilstrup, H1

Reviews

4 review(s) available for lactitol and framycetin

ArticleYear
Nonabsorbable disaccharides for hepatic encephalopathy.
    The Cochrane database of systematic reviews, 2004, Issue:2

    Topics: Anti-Bacterial Agents; Hepatic Encephalopathy; Humans; Lactulose; Neomycin; Randomized Controlled Trials as Topic; Sugar Alcohols

2004
[Nonabsorbable disaccharides for the treatment of hepatic encephalopathy--a systemic review of randomized clinical trials--a secondary publication].
    Ugeskrift for laeger, 2005, Jan-10, Volume: 167, Issue:2

    Topics: Anti-Bacterial Agents; Hepatic Encephalopathy; Humans; Intestinal Absorption; Lactulose; Neomycin; Sugar Alcohols

2005
[Hepatic encephalopathy and liver transplantation].
    Magyar sebeszet, 2012, Volume: 65, Issue:2

    Topics: Ammonia; Anti-Infective Agents; Colon; Dipeptides; Disaccharides; End Stage Liver Disease; Evidence-Based Medicine; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Hungary; Hydrogen-Ion Concentration; Lactobacillus; Lactulose; Laxatives; Liver Cirrhosis; Liver Transplantation; Metronidazole; Neomycin; Rifamycins; Rifaximin; Severity of Illness Index; Sugar Alcohols; Systemic Inflammatory Response Syndrome; Treatment Outcome

2012
Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis.
    The Cochrane database of systematic reviews, 2016, May-06, Issue:5

    Topics: Disaccharides; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Neomycin; Randomized Controlled Trials as Topic; Sugar Alcohols; Watchful Waiting

2016

Trials

1 trial(s) available for lactitol and framycetin

ArticleYear
Comparative modes of action of lactitol and lactulose in the treatment of hepatic encephalopathy.
    Gut, 1987, Volume: 28, Issue:3

    Topics: Colon; Disaccharides; Fatty Acids, Volatile; Feces; Hepatic Encephalopathy; Humans; Hydrogen-Ion Concentration; Lactulose; Neomycin; Sugar Alcohols

1987

Other Studies

2 other study(ies) available for lactitol and framycetin

ArticleYear
Nonabsorbable disaccharides plus neomycin in hepatic encephalopathy: do they enhance each other?
    Hepatology (Baltimore, Md.), 1990, Volume: 12, Issue:2

    Topics: Absorption; Disaccharides; Drug Synergism; Hepatic Encephalopathy; Humans; Lactulose; Neomycin; Sugar Alcohols

1990
[Lactitol and neomycin: monotherapy or combined therapy in the prevention and treatment of hepatic encephalopathy?].
    La Clinica terapeutica, 1989, Apr-30, Volume: 129, Issue:2

    Topics: Bacteria; Drug Resistance, Microbial; Drug Therapy, Combination; Hepatic Encephalopathy; Humans; Intestines; Neomycin; Sugar Alcohols

1989